Open AccessEfficacy and safety of ombitasvir/paritaprevir/ritonavir/ribavirin in management of Egyptian chronic hepatitis C virus patients with chronic kidney disease
Author(s) -
Sherief Abd-Elsalam,
Yousry Esam-Eldin Abo-Amer,
Mohamed El-Abgeegy,
Samah A Elshweikh,
Heba Fadl Elsergany,
Rehab Ahmed,
Mahmoud Elkadeem,
Nehad Hawash,
Shimaa E. Soliman,
Rehab Badawi,
Ayman Mohammed Abdou Elguindy,
Moataz Yousry Soliman,
Ahmed Abdelhaleem Mohmed,
Loai Mansour
Publication year - 2020
Publication title -
medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.59
H-Index - 148
eISSN - 1536-5964
pISSN - 0025-7974
DOI - 10.1097/md.0000000000021972
Subject(s) - medicine , ribavirin , ombitasvir , paritaprevir , ritonavir , kidney disease , gastroenterology , adverse effect , tolerability , hepatitis c virus , virology , viral load , virus , antiretroviral therapy